Data as of Jun 18
| +0.72 / +11.13%|
The 3 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a +80.81% increase from the last price of 7.19.
The current consensus among 3 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.